When it comes to the occurrence of brain tumors, everyone has their own ideas as to why it happens. While none of these can exactly be cemented, there is no question that they can occur and research is done in order to figure out more about these intricate growths. However, is it possible that a mutated gene in the body can play into how these tumors are formed as a result? Judging by a recent article on the matter, I believe it to be the case.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
This mutated gene deserves to be focused on, especially when given the specifics behind it. The gene in question has been given the name of BRAF and it is one that is seen in tumor samples known as papillary craniopharyngiomas. For those who do not know, these are the ones that are not seen so much in children but rather adults. With the presence of this gene in this tumor type, it should make matters easier for researchers who are seeking out the most optimal types of drugs to incorporate.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
This mutated gene deserves to be focused on, especially when given the specifics behind it. The gene in question has been given the name of BRAF and it is one that is seen in tumor samples known as papillary craniopharyngiomas. For those who do not know, these are the ones that are not seen so much in children but rather adults. With the presence of this gene in this tumor type, it should make matters easier for researchers who are seeking out the most optimal types of drugs to incorporate.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
About the Author:
For further knowledge regarding brain tumors, please visit Voices against Brain Cancer for details.
No comments:
Post a Comment